West, A. C., Martin, B. P., Andrews, D. A., Hogg, S. J., Banerjee, A., Grigoriadis, G., . . . Shortt, J. (2016). The SMAC mimetic, LCL-161, reduces survival in aggressive MYC-driven lymphoma while promoting susceptibility to endotoxic shock. Oncogenesis.

West, A C., B P. Martin, D A. Andrews, S J. Hogg, A. Banerjee, G. Grigoriadis, R W. Johnstone, και J. Shortt. "The SMAC Mimetic, LCL-161, Reduces Survival in Aggressive MYC-driven Lymphoma While Promoting Susceptibility to Endotoxic Shock." Oncogenesis 2016.

West, A C., et al. "The SMAC Mimetic, LCL-161, Reduces Survival in Aggressive MYC-driven Lymphoma While Promoting Susceptibility to Endotoxic Shock." Oncogenesis 2016.